Insight
The rise of preventive gynaecology: What women need to know

Co-written By Dr Claire Gillvray and Tarang Majmudar, Welbeck Cambridge (2026)
Gynaecological cancers, cervical, ovarian, uterine, vaginal, and vulvar, pose a significant health risk across all age groups.
While treatment has advanced in recent years, early detection remains the single most crucial factor in improving survival, reducing the need for invasive treatments, and preserving quality of life.
Why Early Detection Matters
When gynaecological cancers are detected early, the five-year survival rate exceeds 90 per cent.
In contrast, late-stage diagnosis can reduce survival chances by more than half. Early detection truly can mean the difference between life and death.
In England, the introduction of cervical screening in 1998 and HPV vaccination in 2008 has drastically reduced the incidence and mortality associated with cervical cancer.
For endometrial cancer, postmenopausal bleeding is a red flag symptom, prompting timely medical intervention and generally resulting in early diagnosis.
Yet, ovarian and vulval cancers often go unnoticed.
Ovarian cancer’s vague symptoms such as bloating, abdominal discomfort, and appetite changes, are frequently mistaken for benign conditions.
Vulval cancer symptoms like itching or soreness are often overlooked, especially post-menopause.
To improve early detection, a threefold strategy is essential:
- Screening
- Symptom recognition
- Lifestyle modification
1. Screening
Cervical cancer is one of the few gynaecological cancers that is both preventable and detectable through routine screening.
Caused primarily by the human papillomavirus (HPV), cervical cancer rates have dropped significantly due to HPV vaccination and cervical screening programmes.
In 2023, NHS England outlined its goal to eliminate cervical cancer by 2040.
Despite high HPV vaccination coverage (approximately 80 per cent), screening uptake has declined, particularly among younger women, where participation has dropped to 70 per cent.
The upcoming introduction of self-sampling for HPV aims to address this gap and improve participation.
However, no effective population-wide screening methods currently exist for ovarian, uterine, vaginal, or vulvar cancers.
This reality reinforces the importance of self-awareness, recognising symptoms, and attending regular gynaecological check-ups.

Dr Claire Gillvray
2. Recognising Warning Symptoms
Awareness of key symptoms is vital for early diagnosis:
- Cervical cancer: abnormal vaginal bleeding, post-coital bleeding, unusual discharge
- Ovarian cancer: persistent bloating, pelvic discomfort, urinary urgency, loss of appetite, weight loss
- Uterine cancer: postmenopausal bleeding, irregular or heavy periods
- Vaginal cancer: unusual bleeding or discharge
- Vulvar cancer: itching, pain, lumps, or ulceration
Although many of these symptoms can have benign causes, persistence or change from the norm should always prompt medical review.
Historically, women’s gynaecological symptoms have often been minimised or dismissed.
This has led to diagnostic delays for conditions like endometriosis, which still takes nearly 9 years on average to diagnose.
Young women are particularly vulnerable, with symptoms too often attributed to hormonal changes or stress.
Rather than placing blame, we must push for better education, research funding, and structural support to help clinicians, especially in primary care, identify early warning signs across diverse age groups and health backgrounds.
3. Lifestyle and Risk Reduction
Healthy habits can reduce the risk of several gynaecological conditions:
- Maintain a healthy weight
- Eat a balanced, nutrient-rich diet
- Avoid tobacco and limit alcohol
- Get vaccinated for HPV and practice safe sex
- Attend regular health checks
- Manage conditions like diabetes and hypertension
- Seek genetic counselling if there’s a family history of breast, bowel, or gynaecological cancers
Prevention isn’t only about medical care, it’s also about empowering people with the knowledge and tools to take charge of their health.
The Role of Men and Partners in Gynaecological Health
Preventative gynaecology isn’t a “women-only” issue. Men and partners play an essential role in recognising early warning signs, supporting open health conversations, and advocating for equitable care.
Awareness campaigns must include all genders, so that everyone can support informed decisions, challenge stigma, and help normalise seeking help early.
The Rise of FemTech
Preventative gynaecology is being transformed by FemTech with technologies including:
- Menstrual tracking apps
- Wearable hormone monitors
- At-home diagnostics
- AI-powered symptom tools
These innovations give people more insight into their own health and more confidence when seeking care.
Yet, technology alone isn’t enough. It must be paired with systemic changes in how symptoms are recognised and responded to.
Chronic pain, abnormal bleeding, and fatigue are too often normalised, leading to prolonged suffering and delayed diagnoses.
Empowering Through Self-Advocacy

Tarang Majmudar
A central tenet of preventative gynaecology is self-advocacy. This involves:
- Know your normal—cycles, mood, energy, libido
- Use tech to track symptoms and patterns
- Push for answers when something feels “off”
- Recognise that stress, sleep, and environment all play a role in health
Empowerment also means expecting and demanding respectful, informed care. It’s about being heard, not dismissed.
Prevention in Action: Real Progress
We’re already seeing the benefits of preventative measures:
- The HPV vaccine is reducing cervical cancer rates significantly.
- Early hormone therapy during perimenopause can protect bone, brain, and heart health.
- Growing awareness of reproductive conditions is shortening the diagnostic journey for many.
When supported by data and technology, people can have more meaningful conversations with healthcare providers and make informed choices about their bodies and care.
Looking Forward
For individuals:
Use digital tools to track trends and flag changes. Treat this data as a conversation starter, not a diagnosis.
For clinicians:
Engage with new technologies. Ask proactively about menstrual, hormonal, and sexual health.
For innovators:
Design inclusive, accessible tools for all bodies, all ages, all ethnicities.
For policymakers and researchers:
Support funding for research that focuses on earlier detection, better diagnostics, and equitable access to care.
The future of gynaecological care is not just about reacting to disease, it’s about preventing it, detecting it early, and empowering everyone to take control of their health.
Preventative gynaecology is more than a trend, it’s a necessity.
With education, accessible tools, cultural change, and collaborative action, we can make early detection the norm, not the exception.
News
Women shouldering hidden burden of navigating healthcare system – study

Women face a hidden burden navigating healthcare, with many repeatedly retelling their medical history, a national study suggests.
The findings indicate that Canadian women are taking on cognitive, emotional and administrative work alongside managing their health, including coordinating providers and advocating for care.
More than half of women surveyed, 53 per cent, reported a past or current chronic condition, while 64 per cent said there were health topics they struggled to raise with their doctor.
Sarah Hoffman, president and CEO of Pacific Blue Cross, said: “These findings challenge us to think differently about women’s healthcare and highlight the hidden work required to navigate the system.
“For many women, managing their health has also come to mean managing the healthcare system itself.
“They are acting as project managers of their own care, shouldering the invisible labour of coordinating between providers, retelling their medical history and advocating to be heard.
“The gap between men and women is meaningful and raises important questions about why younger women report lower levels of confidence and support.
“It also challenges us to consider whether we are actually making progress in women’s care, and whether the next generation is being equipped with the confidence and voice to advocate for their health.”
Overall, 71 per cent of Canadians described their doctors as supportive and 88 per cent expected their appointments to go well.
Among women living with chronic conditions, 71 per cent reported having to repeat their complete health history multiple times a year.
Younger women were particularly likely to report difficulties discussing their health. The study found 81 per cent of Gen Z women aged 18 to 30 and 73 per cent of Millennial women aged 31 to 45 had health topics they struggled to raise with their doctor.
Among Gen Z women with chronic illness, 92 per cent reported having to repeat their complete health history.
The study also found differences between young women and men. While 95 per cent of Gen Z men expected a doctor’s appointment to go well, the figure was 82 per cent among Gen Z women.
Similarly, 82 per cent of Gen Z men said they felt supported by their family doctor, compared with 66 per cent of Gen Z women.
Reasons for holding back health concerns varied between generations.
Among Gen Z women, 30 per cent cited fear of dismissal and 29 per cent fear of judgement.
Embarrassment was the most common barrier among Millennial, Gen X and Boomer women, reported by 29 per cent, 27 per cent and 35 per cent respectively.
Women who felt they needed to prove themselves to be taken seriously said they adapted how they approached appointments.
Strategies included researching medical information, repeatedly describing or justifying symptoms, bringing written notes or documentation, tracking symptom timelines, making repeat visits and emphasising how symptoms affected their daily lives.
The study also found an association between feeling supported by a doctor and expecting appointments to go well.
Canadians who described their physician as supportive were nearly four times more likely to expect appointments to go well than those who felt unsupported, at 98 per cent compared with 25 per cent.
Overall, 66 per cent of Canadians said they described their symptoms accurately. This fell to 48 per cent among those who said they felt unsupported by their doctor.
The 2026 Blue Cross Women’s Health Study surveyed 2,045 adult Canadians online in March 2026 through independent research company Research + Knowledge = Insights.
The survey had a reported margin of error of plus or minus 2 per cent, 19 times out of 20.
Insight
Court recognises radiation as factor in flight attendant’s breast cancer
Insight
Study to tackle years-long delays in endometriosis diagnosis

A study is examining where delays occur in diagnosing endometriosis – a condition that can take seven to twelve years to diagnose.
Endometriosis affects an estimated 1.5 million women and people in the UK, but there is currently no consistent way of measuring where and why diagnostic delays happen.
The research aims to develop the first standardised framework for understanding the diagnostic journey and identifying points where interventions could improve care.
The international project involves researchers from the University of Sheffield, University of Liverpool, University of Oxford, Aarhus University in Denmark and the University of Edinburgh, alongside Endometriosis UK.
Dr Rebecca Mawson, NIHR clinical lecturer in primary care at the University of Sheffield, is part of the research team.
She said: “Our project asks: where exactly are people getting lost or let down on their journey to diagnosis, and how can we map those points in a systematic way to identify where interventions could make a real difference.”
The project is led by Dr Babu Karavadra, NIHR academic clinical fellow in general practice at the University of Liverpool, who has been awarded a World Endometriosis Society Early Career Investigator Award as lead principal investigator at the University of Liverpool.
Researchers will review existing evidence, gather experiences from people living with endometriosis and bring together an international panel to map the diagnostic pathway and agree common definitions for key points along the journey.
The work will focus particularly on people whose experiences are often missing from research, including Black women, people living in rural or deprived areas, LGBTQ+ communities and disabled people.
Primary care will also be central to the research because it is often where people first seek help with symptoms.
Mawson said: “Primary care needs to be at the heart of this work. Primary care is often where people first seek help with their symptoms, so it has a crucial role in understanding diagnostic delay.
“If we only look at what happens once someone reaches specialist gynaecology, we risk missing some of the barriers that shape the journey long before that point.”
Unlike cancer research, where internationally recognised standards exist for studying diagnostic delays, endometriosis research has been more fragmented, with studies measuring different parts of the diagnostic journey in different ways.
The researchers hope to create an ‘Endometriosis Diagnostic Pathway Framework’ to help identify where people are falling through the gaps and where healthcare could be improved.
They will also develop a ‘Snakes and Ladders’ style visual representation showing how systemic barriers, chance and individual experiences can influence whether someone reaches a diagnosis.
The project forms part of the PEARL network, Primary care Endometriosis and Adenomyosis Research and Learning, an international collaboration of primary care and community researchers and clinicians.
Mawson said: “Endometriosis diagnostic delay isn’t inevitable. If we can understand where and why people are experiencing barriers, we have a much better chance of designing interventions that actually make a difference.
“The scale of the problem demands that we look at the whole journey, listen to the people experiencing it and build an evidence base that can lead to real change.”
The framework could provide the foundations for future research, clinical guideline development, healthcare professional training and NHS service improvements, with potential applications to related conditions such as adenomyosis and chronic pelvic pain.
Hormonal health2 weeks agoMajor UK study could be a ‘game-changer’ for heavy periods and endometriosis
Entrepreneur5 days agoKOVE Medical raises €1.7 million to improve safety of foetal surgery
Fertility2 weeks agoOne week left to apply: W Accelerate with Merck KGaA and M Ventures
Pregnancy6 days agoUK study aims to transform maternity care for high-risk pregnancies
Menopause2 weeks agoQuarter of women miss work due to menstual symptoms, survey finds
Mental health1 week agoPMDD after SSRIs or hormones: Why the brain may be the missing treatment target
Cancer1 week agoArk Surgical secures further institutional backing to accelerate US expansion
Insight2 weeks agoStudy to tackle years-long delays in endometriosis diagnosis














2 Comments